I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

Engineering Technician 2

Full-TimeUpdated on 10/23/2026
$24.99 - $36.65/hr+ Cash-based incentive + Overtime pay + Shift differentials + Call-in pay + 401(k) match
Mid, Senior
Associate's
Plymouth, MN, USA
In Person
Manufacturing & Production OperationsProduct Assembly

About the job

Requirements
  • An associate degree in engineering technology, manufacturing technology, electronics, mechanical technology, or a related technical field, with 3–5 years of relevant experience; alternatively, a high school diploma or equivalent with 7–10 years of relevant technical or manufacturing experience.
  • Ability to perform precise, repetitive assembly and inspection activities under a microscope.
  • Ability to operate vision systems, microscopes, measurement equipment, and basic manufacturing tools.
  • Ability to read and interpret technical drawings, specifications, procedures, and manufacturing work instructions.
  • Strong attention to detail and commitment to accurate documentation and data entry.
  • Basic understanding of tooling, equipment, manufacturing processes, inspection methods, and troubleshooting.
  • Ability to follow approved procedures while recognizing and communicating unexpected conditions.
  • Proficiency with computers and commonly used programs such as Microsoft Excel, Word, and electronic documentation systems.
  • Strong mechanical aptitude and practical problem-solving skills.
  • Ability to manage multiple assignments and adjust to changing engineering and manufacturing priorities.
  • Ability to work independently with appropriate direction and collaboratively within a cross-functional team.
  • Willingness to learn new equipment, processes, products, and inspection techniques.
  • Demonstrated initiative, dependability, flexibility, and a positive can-do attitude.
Responsibilities
  • Adhere to applicable safety, environmental, security, and quality requirements, including the Quality Management System, FDA regulations, company policies, operating procedures, and other regulatory requirements.
  • Build and assemble prototype, development, and production-equivalent medical-device components according to drawings, work instructions, and engineering direction.
  • Perform detailed product assembly and inspection under a microscope.
  • Operate microscopes, vision inspection systems, measurement equipment, and other tools used to evaluate product quality and dimensional requirements.
  • Record inspection results, process information, observations, and experimental data in approved datasheets, forms, and electronic systems.
  • Set up and perform engineering experiments, trials, tests, and development builds under the direction of an engineer.
  • Inspect tooling and equipment and assist with preparing, executing, and documenting Installation Qualification activities and reports.
  • Assist engineers with developing, editing, improving, and maintaining manufacturing work instructions, inspection instructions, datasheets, and other controlled documentation.
  • Review documentation for clarity, accuracy, completeness, and usability on the manufacturing floor.
  • Provide on-floor technical support to R&D and Production personnel by answering process and documentation questions and performing initial troubleshooting.
  • Identify product, process, tooling, equipment, or documentation issues and promptly communicate findings to the responsible engineer or supervisor.
  • Support troubleshooting by gathering information, documenting observations, inspecting product, and assisting with basic equipment or process evaluations.
  • Assist with setup, evaluation, modification, and maintenance of tools, fixtures, equipment, and manufacturing processes within the technician’s training and authorization.
  • Provide practical feedback to engineers regarding manufacturability, tooling, equipment operation, inspection methods, and work-instruction effectiveness.
  • Support training of personnel on approved equipment, inspection methods, manufacturing processes, and work instructions, as assigned.
  • Write or contribute to technical reports, qualification reports, test summaries, and other required documentation.
  • Maintain organized work areas, tools, samples, records, and equipment in accordance with cleanroom and quality-system requirements.
  • Collaborate with Engineering, Manufacturing, Quality, Operations, and other departments.
  • Perform other duties as assigned.
Desired Qualifications
  • Previous experience in medical-device manufacturing, regulated manufacturing, cleanroom operations, or precision assembly is preferred.
  • Experience performing detailed assembly or inspection under a microscope is strongly preferred.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Adoption Assistance
  • Parental Leave
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Paid Vacation
  • Paid Holidays

Growth & Insights and Company News

6 month growth

1%

1 year growth

0%

2 year growth

0%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.